The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1E,37,4E)-1-(4-((2-chlorobenzyl)oxy)phenyl)-5-(pyridin-2-yl)penta-1,4-dien-3-one-O-(8-methyIquinazolin-4-yl)oxime ID: ALA4744039
PubChem CID: 162645283
Max Phase: Preclinical
Molecular Formula: C32H25ClN4O2
Molecular Weight: 533.03
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc2ncnc(O/N=C(/C=C/c3ccc(OCc4ccccc4Cl)cc3)\C=C\c3ccccn3)c12
Standard InChI: InChI=1S/C32H25ClN4O2/c1-23-7-6-11-30-31(23)32(36-22-35-30)39-37-27(17-16-26-9-4-5-20-34-26)15-12-24-13-18-28(19-14-24)38-21-25-8-2-3-10-29(25)33/h2-20,22H,21H2,1H3/b15-12+,17-16+,37-27-
Standard InChI Key: UUFJGXSPRFIQRE-VPQGURCKSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
36.2398 -12.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2386 -13.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9467 -13.9073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9449 -12.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6535 -12.6752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6543 -13.4942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3628 -13.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0711 -13.4905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.0663 -12.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3572 -12.2650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3645 -14.7185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6576 -15.1285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6593 -15.9457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9525 -16.3558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3679 -16.3529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0747 -15.9428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2439 -15.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5371 -16.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8319 -15.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1256 -16.3579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1268 -17.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8403 -17.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5438 -17.1712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4205 -17.5870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7114 -17.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0051 -17.5918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7833 -16.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2991 -17.1812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5932 -17.5916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5956 -18.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3096 -18.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0125 -18.4030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7813 -17.1662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.4890 -17.5733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1969 -17.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1925 -16.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4842 -15.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9486 -14.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2991 -16.3640 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
13 15 1 0
15 16 2 0
14 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
25 26 1 0
16 27 1 0
26 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 26 1 0
27 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 27 1 0
3 38 1 0
28 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 533.03Molecular Weight (Monoisotopic): 532.1666AlogP: 7.73#Rotatable Bonds: 9Polar Surface Area: 69.49Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.59CX LogP: 8.62CX LogD: 8.62Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.14Np Likeness Score: -0.90
References 1. Su S,Chen M,Li Q,Wang Y,Chen S,Sun N,Xie C,Huai Z,Huang Y,Xue W. (2021) Novel penta-1,4-diene-3-one derivatives containing quinazoline and oxime ether fragments: Design, synthesis and bioactivity., 32 [PMID:33444848 ] [10.1016/j.bmc.2021.115999 ]